Patents by Inventor Arnaud Ythier

Arnaud Ythier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
    Patent number: 8808696
    Abstract: The present invention provides methods and compositions for treatment of hyperproliferative disorders and cancers, including multiple myeloma and Waldenström's macroglobulinemia, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: August 19, 2014
    Assignees: Ares Trading S.A., Zymogenetics, Inc.
    Inventors: Herve Broly, Arnaud Ythier, Eric Sievers
  • Cladribine regimen for treating multiple sclerosis
    Patent number: 8377903
    Abstract: The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: February 19, 2013
    Assignee: Merck Serono SA
    Inventors: Giampiero De Luca, Arnaud Ythier, Alain Munafo, Maria Lopez-Bresnahan
  • Methods for treating B-cell malignancies using a TACI-Ig fusion molecule
    Patent number: 7842292
    Abstract: The present invention provides methods and compositions for treatment of B-cell malignancies, including non-Hodgkin's lymphoma, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: November 30, 2010
    Assignees: Ares Trading S.A., Zymogenetics, Inc., Mayo Foundation for Medical Education and Research
    Inventors: Herve Broly, Arnaud Ythier, Eric Sievers, Sharon J. Busby, Jan Öhrström, Ivan Nestorov, Stephen M. Ansell
  • Cladribine Regimen for Treating Multiple Sclerosis
    Publication number: 20100203017
    Abstract: The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 12, 2010
    Applicant: Merck Serono S.A.
    Inventors: Giampiero De Luca, Arnaud Ythier, Alain Munafo, Maria Lopez-Bresnahan
  • Cladribine regimen for treating multiple sclerosis
    Patent number: 7713947
    Abstract: The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be orally administered and wherein re-treatments are possible.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: May 11, 2010
    Assignee: Merck Serono S.A.
    Inventors: Giampiero De Luca, Arnaud Ythier, Alain Munafo, Maria Lopez-Bresnahan
  • Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
    Publication number: 20070207156
    Abstract: The present invention provides methods and compositions for treatment of hyperproliferative disorders and cancers, including multiple myeloma and Waldenström's macroglobulinemia, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
    Type: Application
    Filed: August 9, 2006
    Publication date: September 6, 2007
    Inventors: Herve Broly, Arnaud Ythier, Eric Sievers
  • Methods for treating B-cell malignancies using a TACI-Ig fusion molecule
    Publication number: 20070071760
    Abstract: The present invention provides methods and compositions for treatment of B-cell malignancies, including non-Hodgkin's lymphoma, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
    Type: Application
    Filed: August 9, 2006
    Publication date: March 29, 2007
    Inventors: Herve Broly, Arnaud Ythier, Eric Sievers, Sharon Busby, Jan Ohrstrom, Ivan Nestorov, Stephen Ansell